Cargando…
Serum neurofilament light chain and initial severity of neurological disease predict the early neurological deterioration in Wilson’s disease
BACKGROUND: In Wilson’s disease (WD), early neurological deterioration after treatment initiation is associated with poor outcomes; however, data on this phenomenon are limited. Our study analysed the frequency and risk factors of early neurological deterioration in WD. METHODS: Early neurological d...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9469052/ https://www.ncbi.nlm.nih.gov/pubmed/36098934 http://dx.doi.org/10.1007/s13760-022-02091-z |
_version_ | 1784788552068890624 |
---|---|
author | Ziemssen, Tjalf Smolinski, Lukasz Członkowska, Anna Akgun, Katja Antos, Agnieszka Bembenek, Jan Kurkowska-Jastrzębska, Iwona Przybyłkowski, Adam Skowrońska, Marta Redzia-Ogrodnik, Barbara Litwin, Tomasz |
author_facet | Ziemssen, Tjalf Smolinski, Lukasz Członkowska, Anna Akgun, Katja Antos, Agnieszka Bembenek, Jan Kurkowska-Jastrzębska, Iwona Przybyłkowski, Adam Skowrońska, Marta Redzia-Ogrodnik, Barbara Litwin, Tomasz |
author_sort | Ziemssen, Tjalf |
collection | PubMed |
description | BACKGROUND: In Wilson’s disease (WD), early neurological deterioration after treatment initiation is associated with poor outcomes; however, data on this phenomenon are limited. Our study analysed the frequency and risk factors of early neurological deterioration in WD. METHODS: Early neurological deterioration, within 6 months from diagnosis, was defined based on the Unified Wilson’s Disease Rating Scale (UWDRS): any increase in part II or an increase of ≥ 4 in part III. In total, 61 newly diagnosed WD patients were included. UWDRS scores, brain magnetic resonance imaging (MRI) scores, copper metabolism parameters, treatment type and serum neuro-filament light chain (sNfL) concentrations at diagnosis were analysed as potential risk factors of early deterioration. RESULTS: Early neurological deterioration was observed in 16.3% of all WD patients; all cases of worsening occurred in the neurological phenotype (27.7%). Higher scores were seen in those who deteriorated compared with those who did not for UWDRS part II (4.3 ± 5.0 vs 2.0 ± 5.9; p < 0.05), UWDRS part III (21.5 ± 14.1 vs 9.3 ± 16.4; p < 0.01) and MRI-assessed chronic damage (3.2 ± 1.6 vs 1.4 ± 2.2; p = 0.006); all these variables indicated the initial severity of neurological disease. Pre-treatment sNfL concentrations were significantly higher in patients who deteriorated compared with those who did not (33.2 ± 23.5 vs 27.6 ± 62.7 pg/mL; p < 0.01). In univariate logistic regression amongst all patients, chronic damage MRI scores, UWDRS part III scores and sNfL concentrations predicated early deterioration. In the neurological WD, only sNFL were a significant predictor. In bivariate logistic regression amongst all patients, sNfL remained the only significant predictor of deterioration when corrected for MRI scores. CONCLUSION: sNfL concentrations are a promising biomarker of the risk of early neurological deterioration in WD. |
format | Online Article Text |
id | pubmed-9469052 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-94690522022-09-13 Serum neurofilament light chain and initial severity of neurological disease predict the early neurological deterioration in Wilson’s disease Ziemssen, Tjalf Smolinski, Lukasz Członkowska, Anna Akgun, Katja Antos, Agnieszka Bembenek, Jan Kurkowska-Jastrzębska, Iwona Przybyłkowski, Adam Skowrońska, Marta Redzia-Ogrodnik, Barbara Litwin, Tomasz Acta Neurol Belg Original Article BACKGROUND: In Wilson’s disease (WD), early neurological deterioration after treatment initiation is associated with poor outcomes; however, data on this phenomenon are limited. Our study analysed the frequency and risk factors of early neurological deterioration in WD. METHODS: Early neurological deterioration, within 6 months from diagnosis, was defined based on the Unified Wilson’s Disease Rating Scale (UWDRS): any increase in part II or an increase of ≥ 4 in part III. In total, 61 newly diagnosed WD patients were included. UWDRS scores, brain magnetic resonance imaging (MRI) scores, copper metabolism parameters, treatment type and serum neuro-filament light chain (sNfL) concentrations at diagnosis were analysed as potential risk factors of early deterioration. RESULTS: Early neurological deterioration was observed in 16.3% of all WD patients; all cases of worsening occurred in the neurological phenotype (27.7%). Higher scores were seen in those who deteriorated compared with those who did not for UWDRS part II (4.3 ± 5.0 vs 2.0 ± 5.9; p < 0.05), UWDRS part III (21.5 ± 14.1 vs 9.3 ± 16.4; p < 0.01) and MRI-assessed chronic damage (3.2 ± 1.6 vs 1.4 ± 2.2; p = 0.006); all these variables indicated the initial severity of neurological disease. Pre-treatment sNfL concentrations were significantly higher in patients who deteriorated compared with those who did not (33.2 ± 23.5 vs 27.6 ± 62.7 pg/mL; p < 0.01). In univariate logistic regression amongst all patients, chronic damage MRI scores, UWDRS part III scores and sNfL concentrations predicated early deterioration. In the neurological WD, only sNFL were a significant predictor. In bivariate logistic regression amongst all patients, sNfL remained the only significant predictor of deterioration when corrected for MRI scores. CONCLUSION: sNfL concentrations are a promising biomarker of the risk of early neurological deterioration in WD. Springer International Publishing 2022-09-13 2023 /pmc/articles/PMC9469052/ /pubmed/36098934 http://dx.doi.org/10.1007/s13760-022-02091-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Article Ziemssen, Tjalf Smolinski, Lukasz Członkowska, Anna Akgun, Katja Antos, Agnieszka Bembenek, Jan Kurkowska-Jastrzębska, Iwona Przybyłkowski, Adam Skowrońska, Marta Redzia-Ogrodnik, Barbara Litwin, Tomasz Serum neurofilament light chain and initial severity of neurological disease predict the early neurological deterioration in Wilson’s disease |
title | Serum neurofilament light chain and initial severity of neurological disease predict the early neurological deterioration in Wilson’s disease |
title_full | Serum neurofilament light chain and initial severity of neurological disease predict the early neurological deterioration in Wilson’s disease |
title_fullStr | Serum neurofilament light chain and initial severity of neurological disease predict the early neurological deterioration in Wilson’s disease |
title_full_unstemmed | Serum neurofilament light chain and initial severity of neurological disease predict the early neurological deterioration in Wilson’s disease |
title_short | Serum neurofilament light chain and initial severity of neurological disease predict the early neurological deterioration in Wilson’s disease |
title_sort | serum neurofilament light chain and initial severity of neurological disease predict the early neurological deterioration in wilson’s disease |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9469052/ https://www.ncbi.nlm.nih.gov/pubmed/36098934 http://dx.doi.org/10.1007/s13760-022-02091-z |
work_keys_str_mv | AT ziemssentjalf serumneurofilamentlightchainandinitialseverityofneurologicaldiseasepredicttheearlyneurologicaldeteriorationinwilsonsdisease AT smolinskilukasz serumneurofilamentlightchainandinitialseverityofneurologicaldiseasepredicttheearlyneurologicaldeteriorationinwilsonsdisease AT członkowskaanna serumneurofilamentlightchainandinitialseverityofneurologicaldiseasepredicttheearlyneurologicaldeteriorationinwilsonsdisease AT akgunkatja serumneurofilamentlightchainandinitialseverityofneurologicaldiseasepredicttheearlyneurologicaldeteriorationinwilsonsdisease AT antosagnieszka serumneurofilamentlightchainandinitialseverityofneurologicaldiseasepredicttheearlyneurologicaldeteriorationinwilsonsdisease AT bembenekjan serumneurofilamentlightchainandinitialseverityofneurologicaldiseasepredicttheearlyneurologicaldeteriorationinwilsonsdisease AT kurkowskajastrzebskaiwona serumneurofilamentlightchainandinitialseverityofneurologicaldiseasepredicttheearlyneurologicaldeteriorationinwilsonsdisease AT przybyłkowskiadam serumneurofilamentlightchainandinitialseverityofneurologicaldiseasepredicttheearlyneurologicaldeteriorationinwilsonsdisease AT skowronskamarta serumneurofilamentlightchainandinitialseverityofneurologicaldiseasepredicttheearlyneurologicaldeteriorationinwilsonsdisease AT redziaogrodnikbarbara serumneurofilamentlightchainandinitialseverityofneurologicaldiseasepredicttheearlyneurologicaldeteriorationinwilsonsdisease AT litwintomasz serumneurofilamentlightchainandinitialseverityofneurologicaldiseasepredicttheearlyneurologicaldeteriorationinwilsonsdisease |